• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从失败走向成功:美国联邦商业烟草监管

Success from failure: US federal commercial tobacco regulation.

作者信息

Jenson Desmond

机构信息

Public Health Law Center, Saint Paul, Minnesota, USA

出版信息

Tob Control. 2022 Mar;31(2):212-215. doi: 10.1136/tobaccocontrol-2021-056918.

DOI:10.1136/tobaccocontrol-2021-056918
PMID:35241590
Abstract

The history of the US Food and Drug Administration's (FDA) regulation of tobacco products is fraught with failures. A first effort to regulate tobacco products was completely dismantled. Despite robust authority to act, the current iteration of the FDA has also struggled to succeed. While the public health community may be frustrated by the lack of progress to date, recent developments have potentially shown advocates a pathway for success.

摘要

美国食品药品监督管理局(FDA)对烟草制品的监管历史充满了失败。对烟草制品进行监管的首次努力被彻底推翻。尽管拥有强有力的行动权力,但FDA的当前版本也一直在努力取得成功。虽然公共卫生界可能对迄今为止缺乏进展感到沮丧,但最近的发展可能为倡导者们展示了一条成功之路。

相似文献

1
Success from failure: US federal commercial tobacco regulation.从失败走向成功:美国联邦商业烟草监管
Tob Control. 2022 Mar;31(2):212-215. doi: 10.1136/tobaccocontrol-2021-056918.
2
The Next 10 Years of Federal Tobacco Regulation: A Road Map to Protect Public Health and Advance Health Equity.未来十年的联邦烟草监管:保护公共健康和推进健康公平的路线图。
J Leg Med. 2020 Jul-Dec;40(3-4):355-368. doi: 10.1080/01947648.2020.1868941.
3
Ten Years of FDA Tobacco Regulation: Lessons for Public Health Stakeholders.十年 FDA 烟草监管:公共卫生利益相关者的经验教训。
J Leg Med. 2020 Jul-Dec;40(3-4):335-353. doi: 10.1080/01947648.2020.1868940.
4
Symposium Introduction: A Decade of the Tobacco Control Act: Progress, Setbacks, and the Future of Tobacco Control.研讨会介绍:《烟草控制法案》十年:进展、挫折与烟草控制的未来。
J Leg Med. 2020 Jul-Dec;40(3-4):285-291. doi: 10.1080/01947648.2020.1867474.
5
The First 10 Years: Reflecting on Opportunities and Challenges of the Tobacco Products Scientific Advisory Committee of the United States Food and Drug Administration.《第一个十年:反思美国食品和药物管理局烟草产品科学咨询委员会的机遇与挑战》。
J Leg Med. 2020 Jul-Dec;40(3-4):293-320. doi: 10.1080/01947648.2020.1868938.
6
Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products.烟草监管科学:为美国食品药品监督管理局烟草制品中心的监管行动提供信息的研究。
Nicotine Tob Res. 2014 Aug;16(8):1045-9. doi: 10.1093/ntr/ntu038. Epub 2014 Mar 17.
7
Anticipating Industry Arguments: The US Food and Drug Administration's Authority to Reduce Nicotine Levels in Cigarettes.预期行业论点:美国食品和药物管理局降低香烟尼古丁含量的权力。
Public Health Rep. 2018 Jul/Aug;133(4):502-506. doi: 10.1177/0033354918776935. Epub 2018 Jun 7.
8
Permissive nicotine regulation as a complement to traditional tobacco control.宽容性尼古丁监管作为传统烟草控制的补充措施。
BMC Public Health. 2005 Feb 24;5:18. doi: 10.1186/1471-2458-5-18.
9
Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future.了解《烟草控制法案》:美国食品药品监督管理局努力使与烟草相关的发病率和死亡率成为美国的过去,而不是未来。
Lancet. 2013 May 4;381(9877):1570-80. doi: 10.1016/S0140-6736(13)60735-7.
10
Federal approaches to the regulation of noncigarette tobacco products.联邦政府对非香烟烟草产品的监管方法。
Am J Prev Med. 2012 Nov;43(5 Suppl 3):S249-54. doi: 10.1016/j.amepre.2012.07.036.